SCHEMBL8106743

SCHEMBL8106743

Cc1ccc(NC(=O)C(NC(=O)OC(C)(C)C)c2ccc3c(c2)C(C)(C)CCC3(C)C)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
CYP26A1 O43174 7/20 0.41
RARB P10826 7/20 0.41
RARG P13631 7/20 0.41
RARA P10276 6/20 0.41
CYP3A4 P08684 4/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41
CYP2C19 P33261 1/20 0.41
CYP26B1 Q9NR63 3/20 0.41
RXRA P19793 2/20 0.39
RXRB P28702 1/20 0.39
CTSS P25774 1/20 0.39
CTSK P43235 1/20 0.39
PGR P06401 1/20 0.38
ADORA3 P0DMS8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8757257 0.91 RARB (0.40) MEN1KMT2ACYP26A1RARBRARG
SCHEMBL8100983 0.90 RARB (0.44) MEN1KMT2ACYP26A1RARBRARG
SCHEMBL8748829 0.90 RARB (0.55) MEN1KMT2ACYP26A1RARBRARG
SCHEMBL8102431 0.89 RARB (0.43) MEN1KMT2ACYP26A1RARBRARG
SCHEMBL8093042 0.88 RORC (0.45) MEN1KMT2ACYP26A1RARBRARG
SCHEMBL8103130 0.86 BACE1 (0.42) CYP26A1CYP3A4ALDH1A1TSHRCYP26B1
SCHEMBL8093109 0.84 RARG (0.43) MEN1KMT2ACYP26A1RARBRARG
SCHEMBL8100687 0.83 CYP3A4 (0.47) KMT2ACYP3A4ALDH1A1TSHRMAPT
SCHEMBL8108607 0.81 RARB (0.35) MEN1KMT2ACYP26A1RARBRARG
SCHEMBL8748606 0.79 RARB (0.40) MEN1KMT2ACYP26A1RARBRARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6051243-A USEFUL IN THE TOPICAL AND SYSTEMIC TREATMENT OF DERMATOLOGICAL CONDITIONS ASSOCIATED WITH A KERATINIZATION DISORDER, DERMATOLOGICAL CONDITIONS (AND THE LIKE) INCLUDING AN INFLAMMATORY AND/OR IMMUNOALLERGIC COMPONENT CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES (FR) 2000-04-18 US disclosed
US-5709867-A TREATMENT OF DERMATOLOGICAL, RHEUMATIC, RESPIRATORY, CARDIOVASCULAR, AND OPHTHALMOLOGICAL DISORDERS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 1998-01-20 US disclosed
EP-0661260-B1 New bi-aromatic compounds derived from amides pharmaceutical compositions and cosmetic compositions containing them and their use CIRD GALDERMA (FR) 1997-03-12 EP disclosed
EP-0661260-A1 New bi-aromatic compounds derived from amides pharmaceutical compositions and cosmetic compositions containing them and their use CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA, ( CIRD GALDERMA) (FR) 1995-07-05 EP disclosed